目錄:MedChemExpress LLC>>多肽產品>> Gap 27 | MCE
CAS | 198284-64-9 | 純度 | 98.03% |
---|---|---|---|
分子量 | 1304.53 | 分子式 | C??H???N??O?? |
供貨周期 | 現貨 | 規(guī)格 | 5 mg |
貨號 | HY-P0139 | 應用領域 | 醫(yī)療衛(wèi)生,化工,生物產業(yè),制藥 |
MCE 的所有產品僅用作科學研究或藥證申報,,我們不為任何個人用途提供產品和服務。
產品活性:Gap 27,,一種合成的 connexin43 模擬肽,,是一種間隙連接抑制劑。Gap 27 與通往第二跨膜連接蛋白區(qū)段的第二細胞外環(huán)的一部分具有保守的序列同源性,。
研究領域:Cytoskeleton
作用靶點:Gap Junction Protein
In Vitro: Gap 27 causes a remarked decrease in the number of both TRAP-positive mononuclear and multinucleated rat osteoclasts cultured on bovine bone slices. The activity of the remaining osteoclasts is found to be diminished by measuring the percentage of osteoclasts with actin rings of all TRAP-positive cells. In addition, the resorbed area in the treated cultures is greatly diminished. Incubation of the carotid artery with the gap junction inhibitor Gap 27 (500?μM) essentially abolishes the hyperpolarization to acetylcholine but it is without effect on that to levcromakalim. In the guinea-pig isolated internal carotid artery, Gap 27 inhibits acetylcholine-induced, endothelium-dependent hyperpolarizations.
In Vivo: Gap 27 (300 μM) inhibits relaxation by 40% in thoracic aorta and the superior mesenteric artery. Gap 27 also attenuates the endothelium-dependent component of the relaxation induced by ATP in thoracic aorta. .
相關產品:Bioactive Compound Library Plus | Peptide Library | AT-1002 | Meclofenamic acid sodium hydrate | Gap 26 TFA | Meclofenamic acid sodium | Danegaptide Hydrochloride | Larazotide | TAT-Gap19 TFA | Tonabersat | Rotigaptide | Peptide5 | Meclofenamic acid-d4 | Gap19 TFA | Carbenoxolone disodium | Meclofenamic acid-13C6
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,,我們致力于為*科研客戶提供前沿的高品質小分子活性化合物;
• 50,000 多種高選擇性抑制劑,、激動劑涉及各熱門信號通路及疾病領,;
• 產品種類涵蓋各種重組蛋白,多肽,,常用試劑盒 ,,更有 PROTAC、ADC 等特色產品,,廣泛應用于新藥研發(fā),、生命科學等科研項目;
• 提供虛擬篩選,,離子通道篩選,,代謝組學分析檢測分析,藥物篩選等專業(yè)技術服務,;
• 設有專業(yè)的實驗中心和嚴格的質控,、驗證體系;
• 提供 LC/MS,、NMR,、HPLC、手性分析,、元素分析等各項質檢報告,,確保產品的高純度、高品質,;
• 產品的生物活性多經各國客戶實驗驗證,;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學研究進展,,為您提供*新的活性化合物,;
• 與世界各大制藥公司及著名科研機構建立了長期的合作。